New vaccine timing could slash pneumonia spread in malawi
NCT ID NCT04078997
First seen Nov 01, 2025 · Last updated May 07, 2026 · Updated 31 times
Summary
This study looked at whether changing the PCV13 vaccine schedule from three doses without a booster (3+0) to two doses plus a booster (2+1) could reduce the spread of pneumococcal bacteria in children and communities in Blantyre, Malawi. Over 3,500 children and adults participated, including vaccinated children and HIV-infected adults. Researchers measured how many people carried the bacteria in their nose to see if the new schedule provides better protection and herd immunity.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for 13-VALENT PNEUMOCOCCAL VACCINE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Malawi-Liverpool-Wellcome Research Programme
Blantyre, Chichiri, P.O. Box 30096, Malawi
Conditions
Explore the condition pages connected to this study.